% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • adrianahook adrianahook Jan 2, 2014 9:16 PM Flag

    Already exists already exists!!! Retails for less than 100 bucks!

    Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd
    Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.

    Early data, already presented at academic meetings, indicates that Medicyte’s upcyte® hepatocytes combine the benefits of quantity (generation of up to 2000 vials per donor) with the quality of primary hepatocytes. Furthermore, upcyte® hepatocytes, grown with a more native 3D morphology in Reinnervate’s alvetex scaffold, seem to outperform their 2D counterparts.

    ‘We are delighted that Medicyte have chosen to put Alvetex®Scaffold at the heart of their new product development plans’ commented Prof Stefan Przyborski, CSO of Reinnervate Ltd. ‘The ability of 3D cells to better predict in vivo responses to therapeutic and environmental challenges makes alvetex scaffold technology an important new tool for scientists’ he added.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.35-0.10(-2.90%)Jun 24 4:02 PMEDT